Elevance Health, Verily
This was the stock's second consecutive day of gains.
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...
Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.
A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...
StockStory.org on MSN10d
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With EstimatesHealth insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results